Prudential Financial Inc Cidara Therapeutics, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$0.77 - $1.16 $20,482 - $30,855
-26,600 Reduced 68.91%
12,000 $11,000
Q1 2023

May 12, 2023
SELL
$0.75 - $1.98 $16,950 - $44,748
-22,600 Reduced 36.93%
38,600 $49,000
Q4 2022

Feb 14, 2023
BUY
$0.48 - $13.08 $3,456 - $94,176
7,200 Added 13.33%
61,200 $0
Q3 2022

Nov 04, 2022
BUY
$0.45 - $13.0 $24,300 - $702,000
54,000 New
54,000 $34,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.83B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email